TruBridge, Inc.
NASDAQ:TBRGMedical - Healthcare Information Services
+$0.00 today
- Market cap
- $393.58M
- Beta
- 1.29
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.30
Volume 0.30M
Average 0.31M
TBRG EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
TruBridge, Inc.NASDAQ: TBRG
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA declines year over year
Q1 FY2026 EBITDA of $4.82M fell 67.2% year over year, behind the -26.5% change in trailing-twelve-month EBITDA. Sequentially, it rose 69.8% from the prior quarter. Over 3 fiscal years it compounded at -3.8% a year.
Context
- EBITDA amounted to 12.2% of revenue in FY2025, up 2.0 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $34M (-19.9%) for the fiscal year ending Dec 2026, a slowdown from the +21.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $4.82M+69.8% QoQ
- Last fiscal yearDec 2025
- $42.46M+21.5% YoY
- LTMMar 2026
- $32.57M-26.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -67.2% | -18.5% | +48.7 pp |
| 1 year | +21.5% | -19.9% | -41.5 pp |
| 3-year CAGR | -3.8% | -2.9% | +1.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 42.46M USD
- Year-over-year change
- +21.5%
- 4-year CAGR
- -0.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 42.46M | +21.5% |
| FY2024 | 2024-12-31 | 34.94M | +327.0% |
| FY2023 | 2023-12-31 | (15.39M) | -132.2% |
| FY2022 | 2022-12-31 | 47.73M | +10.7% |
| FY2021 | 2021-12-31 | 43.11M | — |
EBITDA vs competitors
How TBRG compares with its peers on the latest reported figures
- TBRG's LTM Mar 2026 EBITDA of $32.57M is the highest of the 11 companies compared; the peer median is $6.4M.
- Its year-over-year change of -26.5% is the 8th highest of 11, against a peer median of -3.4%.
- EBITDA amounts to 9.4% of revenue for TBRG, versus a peer median of 18.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $32.57M | -26.5% | -3.8% | 9.4% | |
| LTM Mar 2026 | $27.87M | -32.4% | -15.0% | 20.1% | |
| LTM Mar 2026 | $22.22M | -11.4% | +75.9% | 16.3% | |
| LTM Mar 2026 | $18.9M | +423.3% | — | 17.6% | |
| LTM Feb 2026 | $17.31M | +4.6% | -7.7% | 21.5% | |
| LTM Mar 2026 | $11.6M | +101.6% | — | 4.9% | |
| LTM Mar 2026 | $1.19M | +114.0% | — | 0.5% | |
| LTM Mar 2026 | -$4.22M | -227.5% | — | 1.9% | |
| LTM Mar 2026 | -$26.57M | +5.3% | — | 46.0% | |
| LTM Mar 2026 | -$66.08M | -31.0% | — | 81.4% | |
| LTM Mar 2026 | -$80.8M | -25.3% | — | 198.5% | |
| Peer median (excluding TBRG) | $6.4M | -3.4% | -7.7% | 18.9% | |
Competitors are the stored peer set for TBRG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 280.63M | 326.65M | 339.44M | 342.65M | 346.84M |
| Cost of Revenue | 135.78M | 166.54M | 175.87M | 168.53M | 162.97M |
| Gross Profit | 144.85M | 160.11M | 163.57M | 174.12M | 183.86M |
| Gross Margin | 51.6% | 49.0% | 48.2% | 50.8% | 53.0% |
| Research & Development | 30.39M | 30.93M | 37.25M | 34.46M | 32.56M |
| Selling, General & Admin | 70.46M | 82.1M | 104.2M | 104.05M | 104.2M |
| Operating Expenses | 120.14M | 137.32M | 206.17M | 167.48M | 163.03M |
| Depreciation & Amortization | 16.87M | 23.33M | 26.47M | 28.97M | 26.28M |
| EBITDA | 43.11M | 47.73M | (15.39M) | 34.94M | 42.46M |
| EBITDA Margin | 15.4% | 14.6% | -4.5% | 10.2% | 12.2% |
| Operating Income | 24.71M | 22.78M | (42.6M) | 6.64M | 20.83M |
| Operating Margin | 8.8% | 7.0% | -12.6% | 1.9% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.16M | 6.32M | 12.52M | 16.17M | 12.32M |
| Other Income / Expenses | (1.63M) | (4.7M) | (11.78M) | (16.84M) | (16.96M) |
| Income Before Tax | 23.08M | 18.08M | (54.38M) | (10.2M) | 3.87M |
| Pre-Tax Margin | 8.2% | 5.5% | -16.0% | -3.0% | 1.1% |
| Income Tax Expense | 4.65M | 2.21M | (8.59M) | 10.24M | (485K) |
| Net Income | 18.43M | 15.87M | (45.79M) | (20.44M) | 4.35M |
| Net Margin | 6.6% | 4.9% | -13.5% | -6.0% | 1.3% |
| EPS (Basic) | 1.26 | 1.08 | (3.15) | (1.38) | 0.29 |
| EPS (Diluted) | 1.26 | 1.08 | (3.15) | (1.38) | 0.29 |
| Weighted Avg Shares | 14.29M | 14.36M | 14.19M | 14.3M | 14.49M |
| Weighted Avg Shares (Diluted) | 14.32M | 14.36M | 14.19M | 14.3M | 14.49M |
TruBridge, Inc.
NASDAQ:TBRG
Intrinsic Alpha fair value
Locked
Current Price
$26.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.